1. Home
  2. DNLI vs BANR Comparison

DNLI vs BANR Comparison

Compare DNLI & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • BANR
  • Stock Information
  • Founded
  • DNLI 2013
  • BANR 1890
  • Country
  • DNLI United States
  • BANR United States
  • Employees
  • DNLI N/A
  • BANR N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • BANR Major Banks
  • Sector
  • DNLI Health Care
  • BANR Finance
  • Exchange
  • DNLI Nasdaq
  • BANR Nasdaq
  • Market Cap
  • DNLI 2.1B
  • BANR 2.3B
  • IPO Year
  • DNLI 2017
  • BANR 1995
  • Fundamental
  • Price
  • DNLI $13.60
  • BANR $63.77
  • Analyst Decision
  • DNLI Strong Buy
  • BANR Buy
  • Analyst Count
  • DNLI 16
  • BANR 6
  • Target Price
  • DNLI $37.57
  • BANR $73.80
  • AVG Volume (30 Days)
  • DNLI 1.3M
  • BANR 244.9K
  • Earning Date
  • DNLI 05-06-2025
  • BANR 04-16-2025
  • Dividend Yield
  • DNLI N/A
  • BANR 3.01%
  • EPS Growth
  • DNLI N/A
  • BANR N/A
  • EPS
  • DNLI N/A
  • BANR 4.88
  • Revenue
  • DNLI N/A
  • BANR $601,023,000.00
  • Revenue This Year
  • DNLI N/A
  • BANR $1.10
  • Revenue Next Year
  • DNLI $497.02
  • BANR $6.35
  • P/E Ratio
  • DNLI N/A
  • BANR $13.07
  • Revenue Growth
  • DNLI N/A
  • BANR N/A
  • 52 Week Low
  • DNLI $13.30
  • BANR $42.00
  • 52 Week High
  • DNLI $33.33
  • BANR $78.05
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 34.19
  • BANR 41.88
  • Support Level
  • DNLI $13.67
  • BANR $62.87
  • Resistance Level
  • DNLI $14.84
  • BANR $66.55
  • Average True Range (ATR)
  • DNLI 0.77
  • BANR 1.81
  • MACD
  • DNLI 0.12
  • BANR 0.15
  • Stochastic Oscillator
  • DNLI 9.90
  • BANR 28.59

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

Share on Social Networks: